Top 10 AI Tools for Therapists

Purpose-built AI clinical assistant that generates structured medical notes from doctor-patient conversations with healthcare-specific ambient documentation, but limited to physician workflows rather than broader therapy sessions.

Nabla earns a high operational score on the strength of 85,000+ active clinicians, 15+ EHR integrations including Epic Toolbox and athenahealth Marketplace, a free tier plus flat-rate paid plans ($119/mo), and consistent independent praise for accuracy and ease-of-use—with only minor caveats around occasional peak-traffic latency and MSE/A&P sections needing editing.

Nabla achieves near-top trust scores with SOC 2 Type 2, ISO 27001, HIPAA, GDPR, and NIST certifications all confirmed, an explicit no-audio-storage and no-model-training-on-patient-data policy, a clean public status page, and a $70M Series C in June 2025 signaling strong operational continuity.

Nabla's market position is very strong: $120M total funding (Series C led by HV Capital closed June 2025), named enterprise customers including CVS Health and Children's Hospital LA, Epic Toolbox and athenahealth Marketplace listings, and tier-1 press coverage from STAT News, FierceHealthcare, and Becker's Hospital Review—though G2/Capterra review counts remain modest (~13–15 reviews).

Nabla has a regionally versioned, documented API (us.api.nabla.com / eu.api.nabla.com) with auth guides, an async note generation endpoint, WebSocket streaming, and a changelog, but scores are dragged down by the absence of publicly documented rate limits, a limited mobile SDK footprint (iOS only confirmed), and no mention of LangChain/MCP orchestration support.

Knowledge management app with AI plugins that therapists use for building interconnected client case notes and treatment resources, but it's a general note-taking tool without healthcare-specific workflows or compliance features.

Core KB and note-linking utility is exceptional with 4,351 community plugins, AI via Smart Connections and CoPilot plugins, and a genuinely free full-featured tier, but steep documented learning curve and near-zero native third-party integrations (no Zapier/Make/REST API) cap the score at 71.

Obsidian earns near-perfect privacy marks as a local-first app with explicit no-data-collection and no-AI-training policies, but the absence of third-party security certifications (SOC 2 belongs to a different company) and no public status page limit the trust ceiling to 73.

Strong organic signals—1.5M monthly active users, 100K+ r/ObsidianMD members, ~$25M ARR bootstrapped—but limited verifiable G2/Capterra review counts, no VC funding signal, and no major platform marketplace listing hold the market score to 63.

The TypeScript plugin API is well-documented with official dev docs and 4,351 shipped community plugins proving developer viability, and GitHub repos were updated as recently as May 2026, but the absence of a REST API, native webhooks, or orchestration framework integration caps infrastructure at 63.

Thoughtful AI assistant known for safe, nuanced responses that therapists use for treatment plan drafting and patient communication, but it's a general-purpose tool without healthcare-specific features or compliance guarantees.

Claude delivers strong core task utility with consistent praise for low hallucination, natural writing style, large context window, and Claude Code's project-level understanding, but usage limit complaints on Pro tier and absence of native image generation are persistent, non-blocking friction points.

Anthropic is a safety-focused AI lab with enterprise HIPAA-readiness, SSO, SCIM, and audit logs available, but Trustpilot reports of April 2026 billing issues, unauthorized charges, and account compromises introduce meaningful trust concerns that offset otherwise solid privacy posture.

Claude shows strong market momentum with Sonnet 5 now free-tier default, active quarterly model releases, Claude Code achieving near-perfect G2 scores, and Anthropic's well-known Tier-1 VC backing, though overall G2 review volume remains modest relative to ChatGPT.

The API is versioned and well-documented with competitive token pricing, batch API discounts, and Agent SDK credit pools indicating orchestration maturity, but the June 2026 Fable/Mythos export-control suspension and billing architecture changes introduce platform durability concerns.

AI voice assistant purpose-built for doctors that generates clinical notes from patient conversations with medical-grade accuracy, though more optimized for primary care than specialized therapy workflows.

Suki delivers confirmed clinical-note automation with 72–76% documented time savings, deep bidirectional EHR integration with all four major platforms (Epic, Oracle, athenahealth, MEDITECH), and a KLAS 93.2/100 score — but its $299–$399/user/month enterprise-only pricing with no free tier drags down ROI accessibility significantly.

SOC 2 Type II certified, HIPAA compliant with BAA provided, PHI deidentified before LLM processing, and privacy policy updated May 2025 all support strong trust; a Series D-backed company with $165M raised and active executive hiring adds stability, though no public status page with historical uptime data was found.

Suki leads the ambient AI clinical documentation category with KLAS Best-in-Class 2025 honors, 400+ health system deployments, a $70M Series D at ~$400M valuation in October 2024, and named-enterprise partnership announcements (MedStar, Rush, McLeod Health) driving exceptionally strong market signals.

The developer.suki.ai portal offers a semantically versioned API with auth documentation, iOS/Android SDKs, and a partner SDK enabling ambient documentation embedding — but orchestration readiness is limited to healthcare-native contexts without general AI framework support (LangChain/LlamaIndex), and no public SLA percentage or historical status-page uptime data was found.

AI search engine that extracts findings from peer-reviewed research papers, enabling therapists to quickly access evidence-based treatment studies, though it's built for general scientific research rather than clinical practice.

Consensus delivers strongly on its core academic search mission—8M+ researchers, GPT-5 integration via OpenAI Responses API, 220M papers, and praised in multiple independent reviews—but the absence of a dedicated G2 listing for the academic product (G2 returns a different 'Consensus' demo automation tool) triggers a −10 penalty, pulling the otherwise solid 82 raw score to 72.

Privacy policy updated June 2025, explicit no-data-selling and anonymized query storage confirmed, and zero incidents tracked by IsDown since November 2025 are positives, but no SOC 2 Type II or third-party security certification was found—only self-attested SSL encryption and a help-center security page—capping security certification at 50 and holding trust to 70.

Exceptional market momentum: user base grew from ~400K (August 2024 Series A) to 8–10M researchers by mid-2026, revenue grew 8× in 2025, OpenAI published a featured case study, 170+ university library partnerships are active, and new publisher deals with Sage and ACS were signed in late 2025—all pointing to a breakout vertical AI search player.

The developer surface is strong and improving rapidly—public API with OpenAPI/llms.txt spec, MCP server for Claude and ChatGPT, changelog updated April 2026, and native AI-framework orchestration—but no official Python/JS SDK was found and explicit rate-limit documentation for non-enterprise tiers is absent, keeping the score at 75 rather than higher.

Healthcare-specific AI assistant for medical document analysis and symptom checking that helps therapists review patient information quickly, but lacks session note generation features critical for therapy workflows.

Docus AI delivers a usable freemium consumer health assistant with a meaningful free tier and broadly positive user sentiment on Trustpilot (4.4/11 reviews) and Product Hunt, but lacks a public API, enterprise integrations, and verifiable G2 presence, triggering a −15 penalty that drags the dimension to 47.

The platform claims HIPAA compliance and publishes a privacy policy with a data-deletion path, but no SOC 2 or ISO 27001 certification was found, training-data use is ambiguous, company stability is weak ($750K total raised, 24 staff), and no public status page exists, holding trust at 55.

With only ~11 Trustpilot and ~7 verified reviews, no G2 presence, a last funding round in Feb 2023 (>36 months ago) totaling just $750K, and no recognizable marketplace listings or enterprise customers, Docus scores poorly on market traction; the >36-month funding penalty of −15 pushes the score to 16.

Docus is a consumer health platform with no public API, SDKs, or orchestration hooks; its v2.0 release notes published Feb 2026 confirm active development, and the consumer-tool baseline floor prevents a lower score, yielding 35.

Free AI meeting recorder with automatic summarization that works well for therapy session notes and CRM updates, but lacks healthcare-specific compliance features like HIPAA-compliant storage and clinical terminology.

Fathom dominates its category with 6,684 G2 reviews at 5.0/5, confirmed unlimited free recording, 6,000+ Zapier integrations, native HubSpot/Salesforce/Slack/Asana sync, a public API, 1,443+ G2 mentions praising transcription accuracy, and a Capterra ease-of-use score of 4.97 — the only friction being the free tier's 5 AI summary/month cap.

SOC 2 Type II plus HIPAA and GDPR compliance are confirmed, AI sub-processors (Anthropic, OpenAI, Google) contractually barred from training on customer data, and a Trust Center is published; the score is modestly trimmed by ambiguous opt-out UX details and only minor status-page transparency relative to the product's scale.

Named to G2's 2026 Best Global Software Top 100, HubSpot's Most Used App of 2025, and Business Insider's 2026 unicorn watchlist, with a $73M valuation backed by a $17M Series A (Sep 2024) and 6,684 G2 reviews reflecting strong adoption velocity across individual and enterprise segments.

A public API is live at developers.fathom.ai with weekly changelog updates through May 2026 and GitHub activity as recent as Sep 2025, but versioning details, SDK availability (Python/JS), and webhook/streaming documentation are thin, capping the infrastructure ceiling despite healthy development cadence.

AI meeting notetaker that records and transcribes therapy sessions across video platforms with searchable transcripts, but lacks healthcare-specific security certifications and clinical note formatting templates.

Fireflies.ai earns strong operational marks with 4.7/5 across 746+ G2 reviews, 60+ native integrations, Zapier/Make support, a documented GraphQL API, and a generous free tier with Pro at $10/seat/yr — but output reliability is constrained by known accuracy degradation under noisy conditions and multi-speaker overlap.

SOC 2 Type II, HIPAA, and GDPR compliance are confirmed alongside an explicit no-training-on-user-data policy, but a December 2025 BIPA class-action lawsuit (Cruz v. Fireflies.AI) alleging unconsented biometric data collection materially dents the privacy posture, and a status page showing multiple multi-hour warning events in April–June 2026 tempers incident transparency confidence.

Fireflies reached unicorn status ($1B+ valuation via June 2025 tender offer) while profitable since 2023, claims 20M+ users across 500K+ organizations including 75% of Fortune 500, and secured a high-profile Perplexity AI partnership — among the strongest market signals in the AI meeting assistant category.

The GraphQL API is versioned with a maintained changelog (v2.23+), a developer program exists, and development is active, but rate limits are not clearly documented, no official Python/JS SDK was confirmed, LangChain/MCP orchestration integrations are absent, and the absence of a published SLA alongside recurring multi-hour incidents in 2026 limits platform durability confidence.

AI-powered workspace for organizing client notes and treatment plans with summarization features that therapists use for practice management, but it's a general productivity tool without healthcare compliance or clinical templates.

Notion AI scores strongly on integration depth (MCP, Zapier, Make, native API, Workers) and ease of use (G2 4.6/5, 11,857 reviews), but is penalised on ROI accessibility after the May 2025 removal of the standalone $10 AI add-on forced full AI features exclusively onto the Business tier at $20/user/month, and output reliability draws occasional complaints around database autofill inconsistency.

Notion explicitly confirms customer data is not used to train its models, holds SOC 2 Type II, ISO 27001:2022, and HIPAA certifications, and provides a GDPR DPA — strong pillars — though data is still routed through third-party AI partners (OpenAI, Anthropic) for inference, which introduces minor residual privacy ambiguity.

With 11,857 G2 reviews, 100 million users, $600M ARR, Fortune 500 penetration exceeding 50%, and rapid AI agent product expansion through H1 2026, Notion shows robust adoption velocity and ecosystem signals; the only drag is that its last formal funding round was the 2021 Series D, offset by clear revenue-growth indicators.

Notion's infrastructure is developer-mature: official JS and Python SDKs, a versioned REST API, a public MCP server updated for token efficiency in May 2026, Workers (serverless runtime in beta), webhooks, and a changelog updated through June 2026 — the only gaps are the absence of a publicly downloadable OpenAPI spec and SLA guarantees limited to Enterprise tiers.

AI transcription service that therapists use to capture session conversations with automated summaries, but it's designed for general business meetings and lacks healthcare-specific security certifications and clinical formatting.

Otter.ai delivers well-confirmed core transcription and summarisation with Zoom/Teams/Meet integration, Zapier support, and a meaningful free tier, but transcription accuracy in noisy environments and occasional recording reliability issues keep it out of the top tier.

SOC 2 Type II and HIPAA certifications are strong positives, but a federal class action lawsuit filed in August 2025 alleging non-consensual recording and confirmed use of user audio to train models without an opt-out mechanism apply the −15 training penalty and depress both privacy and stability sub-scores significantly.

Otter reached $100M ARR in March 2025 with a lean 200-person team, earned TechCrunch and CNBC coverage, and launched an MCP-powered Conversational Knowledge Engine in April 2026, but the last external funding round was February 2021 ($50M) with no subsequent raise disclosed.

The April 2026 MCP client launch and active product changelog signal strong development velocity, but the public API is restricted to enterprise customers only, no official SDK exists, and rate limits are undocumented, limiting the developer surface score.